Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Repeated confidence intervals for adaptive group sequential trials.

Cyrus R Mehta1, Peter Bauer, Martin Posch

  • 1Cytel Corporation, Cambridge, MA 02139, USA. mehta@cytel.com

Statistics in Medicine
|October 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc trial).

Vaccine·2026
Same author

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same author

On the Inclusion of Non-Concurrent Controls in Platform Trials With an Interim Analysis.

Statistics in medicine·2026
Same author

Extremity Ultrasound vs. Computed Tomography at the Third Lumbar Vertebra Level for Assessing the Subcutaneous Adipose Tissue-to-Muscle Ratio.

Nutrients·2026
Same author

Design and analysis of randomized clinical trials for onchocerciasis, loiasis and mansonellosis: A systematic review.

PLoS neglected tropical diseases·2026
Same author

Comparison of primary analysis strategies of randomized controlled trials with multiple endpoints with application to kidney transplantation.

Scientific reports·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

This study introduces a method for calculating reliable confidence intervals in adaptive group sequential trials. It ensures the overall Type I error rate is maintained despite design changes, preserving statistical integrity.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Inference

Background:

  • Group sequential trials allow early stopping for efficacy or futility.
  • Adaptive designs permit modifications during a trial, posing challenges for maintaining Type I error rates.
  • Existing methods for confidence intervals in adaptive trials require careful consideration of error rates.

Purpose of the Study:

  • To develop a method for computing conservative confidence intervals in group sequential trials with adaptive design changes.
  • To preserve the overall Type I error rate despite one or more adaptive modifications.
  • To extend the principle to construct one-sided confidence intervals using repeated confidence intervals (RCIs).

Main Methods:

  • Preserving the null conditional rejection probability at each adaptive change point.

Related Experiment Videos

  • Extending the principle to one-sided confidence intervals via dual tests.
  • Applying the methodology to a sequence of adaptive repeated confidence intervals (RCIs).

    • Main Results:

    • The proposed method successfully preserves the overall Type I error rate under adaptive design changes.
    • Adaptive RCIs maintain desired coverage probability even when stopping rules are altered.
    • Simulations confirm the statistical methodology's validity.

    Conclusions:

    • The method provides a robust approach for confidence interval computation in adaptive group sequential trials.
    • Adaptive RCIs offer a valuable tool for maintaining statistical validity in flexible clinical trial designs.
    • The approach is applicable to real-world clinical scenarios, as demonstrated in a Parkinson's disease trial.